MIT-Hood Pediatric Innovation Hub convenes leaders to advance pediatric health
The Hood Pediatric Innovation Hub brings together clinicians, researchers, and industry to bridge the gap between discovery and care.
The Hood Pediatric Innovation Hub brings together clinicians, researchers, and industry to bridge the gap between discovery and care.
Angela Koehler, Iain Cheeseman, and Katharina Ribbeck are shaping the collaborative as a platform for transformative research, translation, and talent development across MIT.
Therapeutic antibodies packaged into microparticles could be injected with a standard syringe, avoiding the need for lengthy and often uncomfortable infusions.
Using a versatile problem-solving framework, researchers show how early relapse in lymphoma patients influences their chance for survival.
The technology would allow battery-free, minimally invasive, scalable bioelectronic implants such as pacemakers, neuromodulators, and body process monitors.
Professors Facundo Batista and Dina Katabi, along with three additional MIT alumni, are honored for their outstanding professional achievement and commitment to service.
MIT CSAIL and McMaster researchers used a generative AI model to reveal how a narrow-spectrum antibiotic attacks disease-causing bacteria, speeding up a process that normally takes years.
By enabling rapid annotation of areas of interest in medical images, the tool can help scientists study new treatments or map disease progression.
MIT CSAIL researchers developed a tool that can model the shape and movements of fetuses in 3D, potentially assisting doctors in finding abnormalities and making diagnoses.
Cache DNA has developed technologies that can preserve biomolecules at room temperature to make storing and transporting samples less expensive and more reliable.
Advance from SMART will help to better identify disease markers and develop targeted therapies and personalized treatment for diseases such as cancer and antibiotic-resistant infection.
VaxSeer uses machine learning to predict virus evolution and antigenicity, aiming to make vaccine selection more accurate and less reliant on guesswork.
Tools build on years of research at Lincoln Laboratory to develop a rapid brain health screening capability and may also be applicable to civilian settings such as sporting events and medical offices.
Ianacare, co-founded by Steven Lee ’97, MEng ’98, equips caregivers with the resources, networks, and tools they need to support loved ones.
The Language/AI Incubator, an MIT Human Insight Collaborative project, is investigating how AI can improve communications among patients and practitioners.